Bioceltix S.A. GPW:BCX:
SAID ON MONDAY THAT IT HAD SIGNED AN ADVISORY AGREEMENT FOR REGULATORY SUPPORT OF VETERINARY STEM CELL PRODUCTS IN US MARKET
PARTNER TO ASSIST IN DIALOGUE WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND CENTER FOR VETERINARY MEDICINE (CVM)
AGREEMENT SIGNED FOR PERIOD OF UP TO 3 YEARS
ESTIMATES ABOUT 6 TO 9 MONTHS TO REACH FIRST MEETING WITH FDA/CVM
POTENTIAL ADMINISTRATIVE FEE TOTALS $165,441 IF FEE WAIVER IS NOT GRANTED
Source text:
Further company coverage: